According to the New York Times, a start-up says it has used viruses designed by artificial intelligence to treat a human patient, which would be a first. The claim comes from the company and the scientists involved, and the article text could not be fully reviewed here, so details of the patient, the outcome and any independent verification remain unconfirmed. If it holds up, it would mark a step from AI-generated genomes in the lab towards clinical use.